Intellex Acquires Expert by Big Village

We're thrilled to announce that Intellex has acquired Expert by Big Village, effective March 22, 2024. This strategic move enhances our capabilities and strengthens our commitment to delivering exceptional solutions to our customers.

Stay tuned for more updates on how this acquisition will benefit our clients and experts.

For inquiries or more information, please contact us at info@intellex.com.

×

Expert Details

Nanobiotechnology, Drug Delivery Platforms, Medical Devices, Targeted Therapeutics, Diagnostics

ID: 725176 California, USA

Request Expert

Expert has extensive experience establishing R&D operations in early stage biotechnology companies. He applied his knowledge in nano(bio)technology to develop innovative solutions to drug delivery and drug targeting challenges. His efforts to enhance the use of biomaterials in a variety of applications range from medical devices over nanoparticle-based medicines to the creation of novel solutions in fight against worldwide antimicrobial drug resistance. Internationally, Expert has been professionally involved in many countries in Europe and in the Middle East, in the latter where he assisted building a biotechnology research infrastructure.

Expert has over 10 years of direct involvement with start-up and early-stage biotechnology companies in a variety of fields including nanotechnology, medical imaging, medical devices, biomaterials, antibacterials, and cancer medicines.

Over the last 10 years, Expert has developed many innovative approaches and solutions to optimize the delivery of medicines in order to improve their potency and reduce their side-effects. Using his technological insight novel drug candidates that normally would otherwise fail due to poor pharmacological properties can be formulated in delivery vehicles rendering them into promising medicines.

Expert applied his knowledge in protein biochemistry to isolation and purification challenges of protein therapeutics and other biotechnological relevant proteins.

Assessment of emerging bioscience technologies.Provided insight and strategic advice to formulation, targeting, and biological evaluation of nanoparticle-based product candidates.Contributed expertise to several start-up companies.Advised the regional headquarters (EMRO) of the World Health Organization on establishing an antimicrobial surveillance network in the Middle East.

Education

Year Degree Subject Institution
Year: 1993 Degree: PhD Subject: Biochemistry Institution: Biocenter, University of Basel
Year: 1989 Degree: MS Subject: Plant Physiology Institution: Albert-Ludwigs University Freiburg

Work History

Years Employer Title Department
Years: 2006 to Present Employer: Undisclosed Title: Consultant Department:
Responsibilities:
Expert in the assessment of emerging bioscience technologies.
Advanced knowledge of the emerging field of nanobiotechnology.
Contributed expertise to several start-up companies.
Years Employer Title Department
Years: 2007 to 2008 Employer: Cerus Corp. Title: Global Scientific Affairs Manager Department:
Responsibilities:
Scientific promotion of company’s blood safety products for pathogen inactivation through publications and establishment of global support by key opinion leaders.
Develop and execute post-marketing studies to enhance marketability of product portfolio.
Years Employer Title Department
Years: 2006 to 2007 Employer: Nanomix, Inc. Title: Senior Scientist, Technical Lead Department:
Responsibilities:
Developed to beta prototype stage an emergency respiratory medical device product for the measurement of carbon dioxide.
Provided solutions for key issues with protein formulation/analysis, and device shelf-life optimization.
Years Employer Title Department
Years: 1999 to 2006 Employer: Alnis BioSciences, Inc. Title: Principal Scientist Department:
Responsibilities:
Achieved development and implementation of assays and analytical methods in support of in vitro testing and pharmacokinetics/-dynamics.
Advanced the preclinical development of targeted antibacterial and anti-cancer therapeutics, and tumor imaging agents.
Established a project to formulate nanoparticle-encapsulated antibacterials with increased potency.
Co-authored proposals for funding that resulted in 2 contracts with the NIH worth $4.5 millions.
Served as scientific liaise and managed effective collaborations with academic research groups, contract research organizations, and consultants.
Managed isolation and purification of bacterial proteins and toxins as templates for artificial antibodies in a DARPA-funded project.
Provided expertise in setting up the company’s biology laboratory and supervised/ensured its operation.
Years Employer Title Department
Years: 1997 to 1999 Employer: GlaxoSmithKline Title: Senior Scientist Department:
Responsibilities:
Contributed to the design and implementation of optimization strategies for antibacterial lead compounds in collaboration with the Medicinal Chemistry department.
Supported the development of automated assays to increase compound throughput and characterization of antibacterial leads.
Impacted the development of FTIR-based techniques to characterize the antibiotic resistance profile of bacterial pathogens.
Years Employer Title Department
Years: 1995 to 1997 Employer: National Institute of Health and the Environment, Holland Title: Research Fellow Department:
Responsibilities:
Recipient of a fellowship of the European Union.
Co-founder of the European Network for Antimicrobial Resistance and Epidemiology (ENARE).
Development of diagnostic techniques for the genotypic characterization of pathogens and identification of resistance.
Years Employer Title Department
Years: 1996 to 1996 Employer: World Health Organisation Title: Consultant Department:
Responsibilities:
Field visit to Beirut. Provided critical advice and support to establish a surveillance network for antimicrobial resistance in Lebanon.
Authored comprehensive report for and published by the WHO.

International Experience

Years Country / Region Summary
Years: 2008 to 2008 Country / Region: United Arab Emirates/Dubai Summary: Expert provided initial advisory to clients about establishing a research infrastructure for nanobiotechnology.
Years: 2008 to 2008 Country / Region: United Arab Emirates/Sharjah Summary: Expert consulted for the Ministry of Health about the introduction of novel technologies to improve the safety for human health of medical products.
Years: 1996 to 1996 Country / Region: Lebanon/Beirut Summary: Expert consulted for the Eastern Mediterranean Regional Office of the World Health Organization to establish WHO's worldwide surveillance network for antimicrobial resistance. He undertook visits to many of the regions clinical microbiology laboratories.
Years: 1998 to 1998 Country / Region: Egypt/Alexandria Summary: Expert has an assignment with a pharmaceutical manufacturer of generic drugs about establishing an independent research and development program.

Career Accomplishments

Associations / Societies
German American Business Association
Awards / Recognition
SmithKline-Beecham Award (1996)
Publications and Patents Summary
Over thirty publications and one patent in Formulations of Paramagnetic Ion Complexes

Language Skills

Language Proficiency
German Expert is a native German.
Italian He lived in Italy for several years where he acquired his Italian language capabilities.

Fields of Expertise

Request Expert

Dev Tool:

Request: expert/nanobiotechnology-drug-delivery-platforms-medical-devices-targeted-therapeutics-diagnostics
Matched Rewrite Rule: expert/([^/]+)(?:/([0-9]+))?/?$
Matched Rewrite Query: experts=nanobiotechnology-drug-delivery-platforms-medical-devices-targeted-therapeutics-diagnostics&page=
Loaded Template: single-experts.php